Management of Hypotension In Preterm Infants: The HIP Trial Protocol for a Randomized Controlled Trial of Hypotension Management in the Extremely Low Gestational Age Newborn

Trial Profile

Management of Hypotension In Preterm Infants: The HIP Trial Protocol for a Randomized Controlled Trial of Hypotension Management in the Extremely Low Gestational Age Newborn

Recruiting
Phase of Trial: Phase III

Latest Information Update: 04 Feb 2017

At a glance

  • Drugs Dopamine (Primary)
  • Indications Hypotension
  • Focus Registrational; Therapeutic Use
  • Acronyms HIP
  • Sponsors BrePco Biopharma
  • Most Recent Events

    • 27 Jan 2015 Planned End Date changed from 1 Sep 2017 to 1 Jan 2018, according to ClinicalTrials.gov record.
    • 27 Jan 2015 Planned primary completion date changed from 1 Sep 2017 to 1 Jan 2018, according to ClinicalTrials.gov record.
    • 27 Jan 2015 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top